Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer. Yu S, Wu R, Si Y, Fan Z, et al. Oncogene 2024 Aug 20. doi: 10.1038/s41388-024-03134.

Read + Share

Amedeo Smart

Independent Medical Education

Yu S, Wu R, Si Y, Fan Z, et al. Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer. Oncogene 2024 Aug 20. doi: 10.1038/s41388-024-03134.
PMID: 39164523